ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $537,000 | -4.8% | 5,576 | +13.9% | 0.01% | -7.1% |
| Q2 2019 | $564,000 | +4.4% | 4,896 | +6.7% | 0.01% | 0.0% |
| Q1 2019 | $540,000 | +35.0% | 4,590 | -28.2% | 0.01% | +27.3% |
| Q4 2018 | $400,000 | -49.0% | 6,392 | -42.3% | 0.01% | -42.1% |
| Q3 2018 | $785,000 | +9.8% | 11,084 | +3.2% | 0.02% | +5.6% |
| Q2 2018 | $715,000 | +14.0% | 10,744 | +12.1% | 0.02% | +5.9% |
| Q1 2018 | $627,000 | – | 9,588 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |